American Brain Tumor Association-Funded Research Showing Improved Survival for GBM Patients
See on Scoop.it - Brain Tumors
Research published today showing a significant increase in survival for GBM brain tumor patients treated with a tetanus booster in combination with immunotherapy was aided by early funding from the American Brain Tumor Association.
#BrainTumorThursday - GBM brain tumors are highly malignant, aggressive tumors that are most prevalent in adults ages 45-65 and affect more men than women. Long-term survival of this type of tumor is rare — with a median survival of about 14.6 months. #BrainCancer #BrainTumor #BTSM #Caregivers #Caregiving
See on abta.org